- Home
- IPA vs TRIB Comparison
IPA vs TRIB Comparison
Compare IPA & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPA
- TRIB
- Stock Information
- Founded
- IPA 1983
- TRIB 1992
- Country
- IPA Canada
- TRIB Ireland
- Employees
- IPA N/A
- TRIB N/A
- Industry
- IPA Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- IPA Health Care
- TRIB Health Care
- Exchange
- IPA Nasdaq
- TRIB Nasdaq
- Market Cap
- IPA 18.9M
- TRIB 15.8M
- IPO Year
- IPA 2017
- TRIB N/A
- Fundamental
- Price
- IPA $0.44
- TRIB $1.37
- Analyst Decision
- IPA Strong Buy
- TRIB
- Analyst Count
- IPA 2
- TRIB 0
- Target Price
- IPA $6.00
- TRIB N/A
- AVG Volume (30 Days)
- IPA 1.1M
- TRIB 167.2K
- Earning Date
- IPA 12-12-2024
- TRIB 11-15-2024
- Dividend Yield
- IPA N/A
- TRIB N/A
- EPS Growth
- IPA N/A
- TRIB N/A
- EPS
- IPA N/A
- TRIB N/A
- Revenue
- IPA $17,441,886.00
- TRIB $59,126,000.00
- Revenue This Year
- IPA $4.33
- TRIB $17.64
- Revenue Next Year
- IPA $35.64
- TRIB $9.84
- P/E Ratio
- IPA N/A
- TRIB N/A
- Revenue Growth
- IPA 11.21
- TRIB N/A
- 52 Week Low
- IPA $0.35
- TRIB $1.05
- 52 Week High
- IPA $2.60
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- IPA 40.98
- TRIB 36.72
- Support Level
- IPA $0.40
- TRIB $1.30
- Resistance Level
- IPA $0.53
- TRIB $1.70
- Average True Range (ATR)
- IPA 0.07
- TRIB 0.18
- MACD
- IPA 0.00
- TRIB -0.04
- Stochastic Oscillator
- IPA 37.76
- TRIB 7.95
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, Australia and others. The majority of its revenue is derived from United States of America.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.